Pharma-Bio Serv
OTCPK:PBSV
$ 0,50
+ $0,01 (2,04%)
0,50 $
+$0,01 (2,04%)
End-of-day quote: 03/27/2026

Pharma-Bio Serv Stock Value

The current analyst rating for OTCPK:PBSV is sf_No Opinion.
sf_No Opinion

Pharma-Bio Serv Company Info

EPS Growth 5Y
0,00%
Market Cap
$0,01 B
Long-Term Debt
$0,00 B
Short Interest
0,00%
Quarterly earnings
06/13/2026 (E)
Dividend
$0,08
Dividend Yield
15,31%
Founded
1993
Industry
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$1,50
200%
200
Last Update: 03/22/2026
Analysts: 1

Highest Price Target $1,50

Average Price Target $1,50

Lowest Price Target $1,50

In the last five quarters, Pharma-Bio Serv’s Price Target has fallen from $1,99 to $1,81 - a -9,05% decrease. One analysts predict that Pharma-Bio Serv’s share price will increase in the coming year, reaching $1,50. This would represent an increase of 200,00%.

Top growth stocks in the health care sector (5Y.)

What does Pharma-Bio Serv do?

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company focuses on the pharmaceutical, biotechnology, chemical manufacturing, and medical device industries. Business Segments The company operates through three primary business segments: Puerto Rico consulting, United States consulting, and Europe consulting. Each of these segments is managed by distinct management teams and is dedicated to delivering tailored services to meet market-specific...
×